Making bacterial evolution visible in real time: chemistry comes to the aid of biology
AI-generated hypothesis · Pre-publication · To be tested experimentally
Table of contents — full brief
- Hypothesis and mechanismCausal chain, key assumptions, residual unknowns
- State of the artVerified references and counter-evidence (DOIs)
- Falsifiable predictionsQuantitative bounds, statistical tests, H0
- Experimental protocolThree phases — in silico → minimal → full
- Impact analysisNovelty, residual gaps, available data
- Panel reviewFive personas + meta-review
Verified references
5 of 11 references- DOI: 10.1016/j.crphar.2023.100164 ↗
Activity-based protein profiling: A graphical review
2023 - DOI: 10.1038/s41467-023-39063-7 ↗
THRONCAT: metabolic labeling of newly synthesized proteins using a bioorthogonal threonine analog
2023 - DOI: 10.1002/anie.201808493 ↗
One, Two, Three: A Bioorthogonal Triple Labelling Strategy for Studying the Dynamics of Plant Cell Wall Formation In Vivo.
2018 - DOI: 10.1126/science.adh3860 ↗
A rugged yet easily navigable fitness landscape
2023 - DOI: 10.1126/science.aaw2900 ↗
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
2019
+ 6 more references
Detailed panel scores
The protocol incorporates an in silico validation phase (Phase 1) with explicit GO/NO-GO/PIVOT criteria, which permits the filtering of non-viable substrates before the expenditure of substantial experimental resources — an exemplary practice in experimental design.
The hypothesis proposes an elegant and original integration of ABPP (Activity-Based Protein Profiling) with directed evolution, creating a direct and quantifiable link between individual enzymatic activity (fluorescence) and fitness at the population level. This surpasses indirect growth-based measures of fitness.
The idea of directly coupling enzymatic activity to a fluorescent signal via bioorthogonal chemistry is conceptually elegant and could, in theory, permit real-time monitoring of evolution.
A niche but well-identified market: R&D groups in directed evolution at actors such as Codexis, Ginkgo Bioworks, or Arzeda, which today pay millions for blind selection cycles, would have an immediate interest in a system that renders the evolution of an enzyme visible in real time. The time saved on variant optimisation (e.g., for industrial enzymes or biocatalysts) is a direct selling point.
A mechanistically elegant hypothesis is proposed, featuring an innovative coupling between evolutionary selection and real-time phenotypic readout via bioorthogonal chemistry (ABP + click chemistry).
Receive the next SPORE hypotheses
Once or twice a month, in your inbox. No spam, one-click unsubscribe.
Your data stays private. No third-party sharing. GDPR-compliant.